XML 106 R91.htm IDEA: XBRL DOCUMENT v3.22.2
SEGMENT INFORMATION - Narrative (Details) - reporting_unit
3 Months Ended 6 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2022
Ortho Dermatologics      
Segment reporting information      
Number of reporting units   2 2
Salix | Xifaxan Branded Products | Revenue from Contract with Customer, Segment Benchmark | Product Concentration Risk      
Segment reporting information      
Concentration risk percentage 81.00%   80.00%